iopanoic acid has been researched along with Thyrotoxicosis in 11 studies
Iopanoic Acid: Radiopaque medium used as diagnostic aid.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal glands (type II AIT) or in the presence of thyroid abnormalities (type I AIT)." | 9.10 | Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Berti, P; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Martino, E; Materazzi, G; Miccoli, P; Pinchera, A, 2002) |
| "Amiodarone-induced thyrotoxicosis (AIT) may occur either in the presence of underlying thyroid disease (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 9.10 | Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Dell'Unto, E; Grasso, L; Martino, E; Pinchera, A; Rossi, G, 2003) |
| "We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 7.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal thyroid glands (Type II AIT) or in the presence of sub-clinical thyroid abnormalities (either autonomous goiter or latent Graves' disease; Type I AIT)." | 7.71 | Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Basolo, F; Bogazzi, F; Braverman, LE; Cosci, C; Lupi, I; Martino, E; Miccoli, P; Pinchera, A; Santini, F; Tanda, ML, 2002) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal glands (type II AIT) or in the presence of thyroid abnormalities (type I AIT)." | 5.10 | Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Berti, P; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Martino, E; Materazzi, G; Miccoli, P; Pinchera, A, 2002) |
| "Amiodarone-induced thyrotoxicosis (AIT) may occur either in the presence of underlying thyroid disease (type I AIT) or in apparently normal thyroid glands (type II AIT)." | 5.10 | Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. ( Aghini-Lombardi, F; Bartalena, L; Bogazzi, F; Braverman, LE; Brogioni, S; Cosci, C; Dell'Unto, E; Grasso, L; Martino, E; Pinchera, A; Rossi, G, 2003) |
| "We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 3.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
| "Amiodarone-induced thyrotoxicosis is a life-threatening condition." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| " We have now studied the effect of a decrease in serum T3 levels on the GH response to GHRP-6 (1 microg/kg) plus GHRH (100 microg) in 9 hyperthyroid patients before and after 15 days of treatment with iopanoic acid (3 g every 3 days) and propylthiouracil (600 mg/day)." | 3.72 | Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis. ( Lengyel, AM; Nascif, SO; Ramos-Dias, JC; Senger, MH, 2003) |
| "Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal thyroid glands (Type II AIT) or in the presence of sub-clinical thyroid abnormalities (either autonomous goiter or latent Graves' disease; Type I AIT)." | 3.71 | Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Basolo, F; Bogazzi, F; Braverman, LE; Cosci, C; Lupi, I; Martino, E; Miccoli, P; Pinchera, A; Santini, F; Tanda, ML, 2002) |
| "Preoperative thyrotoxicosis is a potentially life-threatening condition that requires medical intervention before surgery." | 2.42 | Perioperative management of the thyrotoxic patient. ( Burch, HB; Langley, RW, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Way, JS | 1 |
| Shen, Y | 1 |
| Martinez, DS | 1 |
| Piga, M | 1 |
| Serra, A | 1 |
| Boi, F | 1 |
| Tanda, ML | 2 |
| Martino, E | 5 |
| Mariotti, S | 1 |
| Matrka, L | 1 |
| Steward, D | 1 |
| Falciglia, M | 1 |
| Nikiforov, Y | 1 |
| Bogazzi, F | 4 |
| Miccoli, P | 3 |
| Berti, P | 2 |
| Cosci, C | 3 |
| Brogioni, S | 2 |
| Aghini-Lombardi, F | 3 |
| Materazzi, G | 2 |
| Bartalena, L | 3 |
| Pinchera, A | 3 |
| Braverman, LE | 3 |
| Dell'Unto, E | 1 |
| Grasso, L | 1 |
| Rossi, G | 1 |
| Langley, RW | 1 |
| Burch, HB | 1 |
| Nascif, SO | 1 |
| Senger, MH | 1 |
| Ramos-Dias, JC | 1 |
| Lengyel, AM | 1 |
| Ambrosini, CE | 1 |
| Braga, M | 1 |
| Cooper, DS | 1 |
| Lupi, I | 1 |
| Santini, F | 1 |
| Basolo, F | 1 |
| Transue, D | 1 |
| Chan, J | 1 |
| Kaplan, M | 1 |
3 reviews available for iopanoic acid and Thyrotoxicosis
| Article | Year |
|---|---|
Iopanoic Acid to Treat Acute Psychiatric Crisis Associated With Thyrotoxicosis: Three Case Reports and Review of the Literature.
Topics: Adult; Female; Humans; Iopanoic Acid; Male; Mental Disorders; Thyrotoxicosis; Young Adult | 2015 |
Amiodarone-induced thyrotoxicosis. A review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Interleukin-6; Iodine; Iodine Radioisotopes; Iopanoic Ac | 2008 |
Perioperative management of the thyrotoxic patient.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Graves Disease; Humans; Iodine; Iopanoic Acid; Peri | 2003 |
2 trials available for iopanoic acid and Thyrotoxicosis
| Article | Year |
|---|---|
Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy.
Topics: Aged; Aged, 80 and over; Amiodarone; Contrast Media; Enzyme Inhibitors; Female; Humans; Hyperthyroid | 2002 |
Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Iodide | 2003 |
6 other studies available for iopanoic acid and Thyrotoxicosis
| Article | Year |
|---|---|
Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Atrial Fibrillation; Contrast Media; Humans; Iopanoic Acid; Male; Middle Aged; Thyroidec | 2008 |
Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.
Topics: Adolescent; Adult; Antithyroid Agents; Area Under Curve; Female; Fluorescent Antibody Technique; Gro | 2003 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Clinical review 129: Oral cholecystographic agents and the thyroid.
Topics: Administration, Oral; Cholecystography; Contrast Media; Humans; Iopanoic Acid; Kidney; Liver; Pituit | 2001 |
Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Resistance; Enzyme Inhibitors; Female; Humans; Iodide P | 2002 |
Management of neonatal Graves disease with iopanoic acid.
Topics: Graves Disease; Humans; Infant, Newborn; Iopanoic Acid; Male; Thyrotoxicosis | 1992 |